Giulia Realini

Giulia earned her bachelor’s degree in Biological Sciences in 2016 and her master’s degree in Molecular and Cellular Biology in 2018, at the University of Siena.
Subsequently, she awarded the PhD in Biochemistry and Molecular Biology at the University of Siena in May 2022, during which she spent a year at Fritz Lipmann Institute (FLI) Leibniz Institute on Aging (Jena, Germany). In these years, she focused her studies on identification of molecular pathways involved in physio-pathological mechanisms and discovery of molecular targets necessary for the development of new drugs to treat Age related Macular Degeneration (AMD).
From March 2022, she worked for one year as scientist at Glaxo Smith Kline Vaccine (Siena) focusing on the construction and validation of in vitro 3D respiratory models for host-pathogen interactions studies.
In March 2023, Giulia joined as a Postdoctoral researcher the “Monoclonal Antibody Discovery Laboratory” (MAD lab), led by Dr. Rino Rappuoli at Fondazione Toscana Life Sciences in Siena. Here, she will be working on Covid-19 and Monkeypox projects.

Research Group: